TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia. [electronic resource]
Producer: 20140317Description: 206-11 p. digitalISSN:- 1527-7755
- Aged
- Antineoplastic Agents, Hormonal -- therapeutic use
- Biomarkers, Tumor -- genetics
- Biopsy
- Disease Progression
- Gene Expression Regulation, Neoplastic
- Gene Fusion
- Humans
- Male
- Middle Aged
- Neoplasm Grading
- Oncogene Proteins, Fusion -- genetics
- Prostatic Intraepithelial Neoplasia -- diagnosis
- Prostatic Neoplasms -- diagnosis
- Toremifene -- therapeutic use
- Up-Regulation
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.